Latest news
Loading news…
Apeximmune Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Burlingame, California, United States Founded 2018 1-10 employees For Profit
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- IT spend
- $57K
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 9
- HQ
- Burlingame, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded; Women Led
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.7
- Trend (90d)
- -0.8
Key People at Apeximmune Therapeutics
Founder & CEO
2
professional contacts at Apeximmune Therapeutics
Contact execs at Apeximmune Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Apeximmune Therapeutics
Loading news…
FAQs about Apeximmune Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.